东星医疗 reported revenue of ¥0.18B for the period ended 2026-06-30, -1.6% year on year. Net income was ¥0.03B, a 18.5% net margin on a 48.5% gross margin. The largest revenue line is 吻合器 at 53% of the total. Free cash flow for the period was ¥0.03B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.18B | -1.6% |
| Gross profit | ¥0.09B | — |
| Operating income | ¥0.04B | — |
| Net income | ¥0.03B | +12.3% |
| Gross margin | 48.5% | Net margin 18.5% |
| Revenue Q/Q | -0.7% | — |
| Segment | Revenue | Share |
|---|---|---|
| 吻合器 | ¥0.09B | 52.6% |
| 吻合器零配件 | ¥0.04B | 22.9% |
| 低值耗材 | ¥0.03B | 14.0% |
| 医疗设备 | ¥0.02B | 8.5% |
| 其他 | ¥0.00B | 2.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.09B | 51.5% |
| R&D | ¥0.01B | 5.4% |
| SG&A | ¥0.05B | 29.7% |
| Tax & other | ¥0.01B | 4.1% |
| Item | Amount |
|---|---|
| Total assets | ¥2.38B |
| Total liabilities | ¥0.22B |
| Shareholders' equity | ¥2.16B |
| Equity / assets | 90.7% |
| Operating cash flow | ¥0.04B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥0.03B |
| Cash conversion (OCF / net income) | 110% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
明阳电气 ・ 海科新源 ・ 三博脑科 ・ 美硕科技 ・ 新巨丰 ・ 富乐德 ・ 东利机械 ・ 卓创资讯 ・ 远翔新材 ・ 川宁生物 ・ 华如科技 ・ 真兰仪表
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies